S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Laser breakthrough could send stock soaring 2,467% (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Court battle over interstate travel targets Utah bus stops in Nevada, California
Laser breakthrough could send stock soaring 2,467% (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Save $200 on MarketBeat All Access (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Laser breakthrough could send stock soaring 2,467% (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Court battle over interstate travel targets Utah bus stops in Nevada, California
Laser breakthrough could send stock soaring 2,467% (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Save $200 on MarketBeat All Access (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Laser breakthrough could send stock soaring 2,467% (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Court battle over interstate travel targets Utah bus stops in Nevada, California
Laser breakthrough could send stock soaring 2,467% (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Save $200 on MarketBeat All Access (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Laser breakthrough could send stock soaring 2,467% (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Court battle over interstate travel targets Utah bus stops in Nevada, California
Laser breakthrough could send stock soaring 2,467% (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Save $200 on MarketBeat All Access (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
NYSE:BTX

Brooklyn ImmunoTherapeutics (BTX) Stock Forecast, Price & News

$2.00
-0.17 (-7.83%)
(As of 06/2/2023 ET)
Compare
Today's Range
$2.00
$2.26
50-Day Range
$1.91
$3.48
52-Week Range
$0.17
$10.10
Volume
27,123 shs
Average Volume
515,543 shs
Market Capitalization
$117.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BTX stock logo

About Brooklyn ImmunoTherapeutics (NYSE:BTX) Stock

Eterna Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.

Receive BTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brooklyn ImmunoTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

BTX Stock News Headlines

Free SMS Trade Alerts. Up to 15 opportunities a day.
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
Brooklyn Technical High School
Brooklyn Preparatory High School
We Called (ARWR) In Advance, Which Stocks Are Next?
Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE.
Brooklyn ImmunoTherapeutics Announces Board Changes
See More Headlines

BTX Price History

Industry, Sector and Symbol

Industry
Television Broadcasting
Sub-Industry
N/A
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$117.65 million
Optionable
Optionable
Beta
4.61

Key Executives

  • Matthew Angel
    President, Chief Executive Officer & Director
  • Andrew C. Jackson
    Chief Financial Officer
  • Roger Sidhu
    Chief Medical Officer
  • Jay Sial
    Chief Administrative Officer
  • Sandra Gurrola
    Principal Accounting Officer & VP-Finance













BTX Stock - Frequently Asked Questions

How have BTX shares performed in 2023?

Brooklyn ImmunoTherapeutics' stock was trading at $3.22 at the beginning of the year. Since then, BTX stock has decreased by 37.9% and is now trading at $2.00.
View the best growth stocks for 2023 here
.

What is Brooklyn ImmunoTherapeutics' stock symbol?

Brooklyn ImmunoTherapeutics trades on the New York Stock Exchange (NYSE) under the ticker symbol "BTX."

How do I buy shares of Brooklyn ImmunoTherapeutics?

Shares of BTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Brooklyn ImmunoTherapeutics' stock price today?

One share of BTX stock can currently be purchased for approximately $2.00.

How much money does Brooklyn ImmunoTherapeutics make?

Brooklyn ImmunoTherapeutics (NYSE:BTX) has a market capitalization of $117.65 million.

How can I contact Brooklyn ImmunoTherapeutics?

The company can be reached via phone at (212) 582-1199.

This page (NYSE:BTX) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -